# Do Paraguayan hospitals need a licence to produce oxygen?

**Does a Paraguayan hospital need a licence to produce oxygen?**

Under Resolution S.G. 208/2009 of Paraguay's Ministry of Public Health and Social Welfare, dated 23 April 2009, medical gases are medicines for human use and establishments covered by it, including producers using PSA molecular sieve concentrators, need the Ministry's authorisation (habilitación) before they operate.

## What the resolution says

Resolution S.G. 208/2009 declares that products defined as medical gases are medicines for human use (Article 1) and applies to the activities of representation, import, production, marketing and distribution of gases for medical use (Article 2). Article 3 defines a medical gas, says oxygen and nitrous oxide are understood as medical gases, and says they can be produced industrially or by processes that use air concentrators with a molecular sieve (PSA). Article 4 says medical gases, whether made by the cryogenic method or by PSA, are made and controlled under a quality assurance system and good manufacturing practices, and meet internationally accepted pharmacopoeia specifications, naming the USP, the European and the French Codex.

## Authorisation

- Article 5.1: establishments covered by the resolution must, before operating, hold an authorisation (habilitación) from the Ministry's competent body.
- Article 5.2: authorisation is granted under the same conditions as for pharmaceutical specialities (Decrees 8343/95 and 8342/95), and products meet the quality specifications and the Mercosur good manufacturing practices for pharmaceutical specialities (GMC/RES. 14/96).
- Article 5.3: establishments already working when the resolution was approved had 6 months to adapt.
- Article 6: marketing of medical gases on the local market is subject to the corresponding authorisation.
- Article 7: the National Directorate of Health Surveillance is in charge of compliance.

## What it does not say, and how a tender read it

The four pages of the resolution published by DINAVISA do not mention hospitals' own plants separately, and they contain no article on a quality control laboratory or a responsible pharmacist (regente). In the questions and answers of the 2019 public tender LPN SBE 133-19 for medical gas installations in IPS hospitals, a bidder cited the resolution as requiring these and asked whether each hospital would seek the authorisation and invest in a laboratory. The contracting body answered that the bidder only had to meet the technical aspect of the rule and that staffing would be assigned by the institution. The same document shows the tender asked for oxygen purity of 93% ± 3%.

Whether a given hospital plant needs the authorisation is a matter for the health authority. The resolution was read on 19 November 2026 as published on the DINAVISA website; later changes to the institutions or the rule were not checked.

### Does the resolution mention PSA plants?

Yes. Article 3 refers to production with air concentrators with a molecular sieve (PSA), and Article 4 applies quality assurance to gases made by the cryogenic method or by PSA.

### How long did existing establishments have to adapt?

Article 5.3 gave establishments already working when the resolution was approved 6 months to adapt.

## Sources

- [Paraguay, Ministerio de Salud Pública y Bienestar Social, Resolución S.G. N° 208/09 (Asunción, 23 April 2009), Articles 1 to 7, copy on dinavisa.gov.py](https://dinavisa.gov.py/wp-content/uploads/2023/08/RESOLUCION-N208-2009.pdf)
- [Paraguay, Dirección Nacional de Contrataciones Públicas, Licitación 372171 LPN SBE 133-19, Consultas realizadas (questions of 21 November 2019, answers of 27 November 2019)](https://www.contrataciones.gov.py/reporte/convocatoria/372171-lpn-sbe-133-19-readecuacion-instalaciones-gases-medicinales-hospitales-ips-1/consultas.pdf)

Reviewed: 2026-11-19. Ultra Controlo engineering. https://library.ultracontrolo.com/answers/is-on-site-oxygen-production-licensed-in-paraguay/
